
Sign up to save your podcasts
Or


We’re living in the big data age, surrounded by personal, scientific, and societal data that could help us understand the world, make decisions, and even forecast what comes next. But complex systems don’t fit neatly into human intuition, and we can’t “see” meaning in massive datasets without help.
Find Katy here:
https://cns-iu.github.io/katy
Read more about data visualization and macroscopes here:
Envisioning Intelligences exhibit call is at https://scimaps.org/call-for-submissions
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
The Rare Lens: AI-based image recognition for rare disease diagnoses
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Cells are the basic units of life. For over a century, understanding cellular processes has been the basis for understanding human development and disease, and for deciphering the actions of novel disease treatments. But there’s a caveat: wet-lab studies in cells take time and money, they are often reductionist. To overcome those challenges of the wet lab, researchers have for some time tried to model cellular processes mathematically, in so-called virtual cells. With the availability of large-scale datasets and sophisticated AI models, virtual cells are advancing into useful tools for researchers.
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Image Aden Lao via unsplash
Selected recent publication from the Theis lab:
Additional background info:
Every second man and every third woman will experience a cancer diagnosis during their lives. Getting the news can be devastating and paralyzing, but making the right decisions about treatment, care, mindset and lifestyle is a crucial part of finding a cure.
Find Stefanie Walther:
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Further reading on the topics we discussed during the episode and found in the book can be found in here:
CANCER FACT AND FIGURES
ESSENTIAL 1: CALM DOWN
ESSENTIAL 2: ASK FOR HELP
ESSENTIAL 3: NAME THE DISEASE
ESSENTIAL 4: FIND A CANCER CENTER FOR ERADICATION
ESSENTIAL 5: I STAY MENTALLY STRONG
ESSENTIAL 6: CHOOSE HEALTHY FOODS
ESSENTIAL 7: ACTIVATE YOUR BODY
ESSENTIAL 8: NORMALIZE YOUR SLEEP
OUTLOOK
This time Louise and Andreas invited the artist Annette Goessel into the show to discuss the once united forces of art and science that seem so seperate in our day and age.
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
It sounds promising: AI chatbots acting as scientists, condensing the work of weeks, months, or even years of reading, debate, and hour-long lab meetings into minutes.
Image: Igor Saikin via Unsplash
References
AI scientists
Self-driving labs
The $600 billion MedTech industry is undergoing a technological transformation. From AI-powered medical imaging to smart diagnostics and remote monitoring tools, artificial intelligence and machine learning are reshaping how care is delivered — and increasingly how patients manage their own health.
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Image: testalize-me-SVmaaACzcJ8-unsplash
Food is a topic that is both deeply personal and of global importance. What we eat affects our health and longevity, but also the lives of animals and the future of our planet.
You can find Lia here: https://www.linkedin.com/in/lia-carlucci-foodtech-entrepreneur-ceo-speaker/?originalSubdomain=de
And Berlin Food campus here: https://www.foodcampus.berlin/
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Image: Markus Spiske via Unsplash
References:
Despite great hopes for Artificial Intelligence (AI) in biotech and pharma—with investments exceeding $50 billion over the past ten years—the question of when the technology will reach maturity remains difficult to answer. How can biotech and pharma leaders navigate this complex gray area, where hype around the technology obscures the outlook and few concrete milestones provide clear signposts for decision-making?
In this episode of the BioRevolution podcast, Louise von Stechow and Andreas Horchler speak with their guest, idalab founder Paul von Bünau, about the potential of AI in biotech. They explore how leaders can adapt internal processes, support their teams in facing the challenges AI brings, and examine whether AI has the potential to make us better leaders.
Find Dr. Paul von Bünau here: https://www.linkedin.com/in/paulvonbuenau/
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Image: Matteo Vistocco via Unsplash
References:
More than 20 years after the Human Genome Project, enabled by new sequencing technologies, researchers are making progress in exploring the vast non-coding space that constitutes 98% of our genomes. This non-coding, or "dark," DNA harbors elements with important regulatory functions in health and disease. But pinpointing disease-relevant DNA elements within this massive DNA space can be like searching for a needle in a haystack. This difficult search can be eased by artificial intelligence (AI)-based tools, which predict the context-dependent relevance of certain DNA elements and highlight their role in different diseases, from cancer to rare neurodegenerative disorders.
Learn more about LUCID genomics AI tool here: https://www.lucid-genomics.com/technology
Find Dr. Hossein Moeinzadeh here: https://www.linkedin.com/in/mhossein-moeinzadeh/
Disclaimer:
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
Image:
From the publisher's feed